|
End-of-day quote
NSE India S.E.
04/09/2026
|
5-day change | 1st Jan Change | ||
| 1,927.60 INR | +3.93% |
|
+3.11% | +41.27% |
| 07/08 | Emcure Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 06, 2026 | |
| 06/08 | Emcure Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026 | CI |
| Market Cap | 366B 3.87B 3.33B 3.14B 2.86B 5.36B 5.37B 37.05B 14.38B 188B 14.54B 14.22B 604B | P/E 2027 * |
30.7x | P/E 2028 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 372B 3.94B 3.39B 3.19B 2.91B 5.45B 5.47B 37.7B 14.63B 191B 14.8B 14.47B 615B | EV / Sales 2027 * |
3.51x | EV / Sales 2028 * | 3.03x |
| Free-Float |
18.24% | Yield 2027 * |
0.21% | Yield 2028 * | 0.25% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| EMCURE | End-of-day quote | |
Bombay S.E.
| EMCURE | Delayed |
Last Transcript : Emcure Pharmaceuticals Limited
| 1 day | +3.93% | ||
| 1 week | +3.11% | ||
| Current month | +3.90% | ||
| 1 month | -1.60% | ||
| 3 months | +9.72% | ||
| 6 months | +32.63% | ||
| Current year | +41.27% |
| 1 week | 1,835 |  | 1,935 |
| 1 month | 1,830.1 | | 2,048 |
| Current year | 1,381 | | 2,048 |
| 1 year | 1,260 | | 2,048 |
| 3 years | 889 | | 2,048 |
| 5 years | 889 | | 2,048 |
| 10 years | 889 | | 2,048 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/1981 | |
| Director of Finance/CFO | - | 01/10/2003 | |
| Compliance Officer | - | 04/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
| Director/Board Member | 73 | 23/07/2001 | |
| Director/Board Member | 75 | 16/04/1981 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.93% | +3.11% | +40.42% | - | 3.87B | |
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | |
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | |
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | |
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | |
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | |
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | |
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | |
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | |
| Average | -0.45% | +1.37% | +29.83% | +52.33% | 368.22B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.63% | +67.00% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 106B 1.12B 965M 908M 830M 1.55B 1.56B 10.73B 4.17B 54.35B 4.21B 4.12B 175B | 120B 1.27B 1.09B 1.03B 938M 1.75B 1.76B 12.13B 4.71B 61.41B 4.76B 4.66B 198B |
| Net income | 11.87B 126M 108M 102M 92.98M 174M 174M 1.2B 467M 6.09B 472M 462M 19.62B | 14.59B 154M 133M 125M 114M 214M 214M 1.48B 574M 7.48B 580M 567M 24.11B |
| Net Debt | 6.38B 67.62M 58.18M 54.74M 50.01M 93.55M 93.8M 647M 251M 3.28B 254M 248M 10.55B | -3.28B -34.72M -29.88M -28.11M -25.68M -48.04M -48.17M -332M -129M -1.68B -130M -128M -5.42B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | INR 1,927.60 | +3.93% | 276,608 |
| 03/09/26 | INR 1,854.70 | -0.20% | 91,447 |
| 02/09/26 | INR 1,858.40 | +0.68% | 93,727 |
| 01/09/26 | INR 1,845.90 | -0.51% | 114,806 |
| 31/08/26 | INR 1,855.30 | -0.75% | 99,105 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EMCURE Stock
Select your edition
All financial news and data tailored to specific country editions
